Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)

In context of limited applicability of the evidence generated in younger or fitter individuals, patient preferences, life expectancy, predicted survival benefits, and effect on anticancer therapy toxicity and quality of life should be carefully considered in decision making.

Source:

The Lancet Oncology